In vitro effects of polyphenols on colorectal cancer cells

World Journal of Gastrointestinal Oncology

Volumn 6, Issue 8, 2014, Pages 289-300

  Pampaloni, Barbara ^a   Palmini, Gaia ^a   Mavilia, Carmelo ^a   Zonefrati, Roberto ^a   Tanini, Annalisa ^a   Luisa Brandi, Maria ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Estrogen receptor; Genistein; HCT8 8 cells; HCT8 pSV2neo; Quercetin

Indexed keywords

EID: 84928938460     PISSN: None     EISSN: 19485204     Source Type: Journal    
DOI: 10.4251/wjgo.v6.i8.289     Document Type: Article

References (61)

1. [1].American Cancer Society. Cancer Facts and Figures 2010. Atlanta: American Cancer Society, 2010. Available from: URL: http: //www.cancer.org/acs/groups/content/@nho/ documents / document / acspc-024113.pdf
2. [2].Chen L, Crawford JM. Tratto Gastrointestinale. In: Robbins and Cotran. Pathologic Basis of Disease, 7th ed. Milan: Else¬vier, 2006: 797-877
3. [3].Wei EK, Colditz GA, Giovannucci EL, Fuchs CS, Rosner BA. Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study. Am J Epidemiol 2009; 170: 863-872 [PMID: 19723749 DOI: 10.1093/ aje/kwp210]
4. [4].Lacassagne A. Endocrine factors concerned in the genesis of experimental mammary carcinoma. J Endocrinol 1955; 13: ix- xviii [PMID: 13278450]
5. [5].American Cancer Society. Cancer Facts and Figures 2007. Atlanta: American Cancer Society, 2007. Available from: URL: http: //www.cancer.org/acs/groups/content/@nho/ documents / document / caff2007pwsecuredpdf.pdf
6. [6].Spector D, Anthony M, Alexander D, Arab L. Soy consumption and colorectal cancer. Nutr Cancer 2003; 47: 1-12 [PMID: 14769532 DOI: 10.1207/s15327914nc4701_1]
7. [7].Wong HL, Peters U, Hayes RB, Huang WY, Schatzkin A, Bresalier RS, Velie EM, Brody LC. Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. Eur J Cancer 2010; 46: 2457-2466 [PMID: 20510605 DOI: 10.1016/j.ejca.2010.04.020]
8. [8].Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. Cancer Res 2001; 61: 632-640 [PMID: 11212261]
9. [9].Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW. Selective loss of estrogen receptor beta in malignant human colon. Cancer Res 2000; 60: 245-248 [PMID: 10667568]
10. [10].Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G, Papavassiliou AG. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 2003; 39: 1251-1258 [PMID: 12763213 DOI: 10.1016/S0959-8049(03)00239-9]
11. [11].Picariello L, Fiorelli G, Martineti V, Tognarini I, Pampaloni B, Tonelli F, Brandi ML. Growth response of colon cancer cell lines to selective estrogen receptor modulators. Anticancer Res 2003; 23: 2419-2424 [PMID: 12894523]
12. [12].Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S, Trentalance A, Muramatsu M, Marino M. Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling. J Cell Physiol 2005; 203: 193-201 [PMID: 15389627]
13. [13]. Galluzzo P, Caiazza F, Moreno S, Marino M. Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr Relat Cancer 2007; 14: 153-167 [PMID: 17395984]
14. [14].Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl 1990; 201: 3-23 [PMID: 2173856]
15. [15].Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001; 74: 418-425 [PMID: 11566638]
16. [16].Barone M, Tanzi S, Lofano K, Scavo MP, Guido R, Demari- nis L, Principi MB, Bucci A, Di Leo A. Estrogens, phytoestrogens and colorectal neoproliferative lesions. Genes Nutr 2008; 27..: 7-13 [PMID: 18850193 DOI: 10.1007/s12263-008-0081-6]
17. [17].Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, Harper P. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 2006; 136: 3046-3053 [PMID: 17116718]
18. [18].Ascenzi P, Bocedi A, Marino M. Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med 2006; 27: 299-402 [PMID: 16914190]
19. [19].Sarkar FH, Li Y. Soy isoflavones and cancer prevention. Cancer Invest 2003; 21: 744-757 [PMID: 14628433]
20. [20].Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 1995; 103 Suppl 7: 103-112 [PMID: 8593855 DOI: 10.2307/3432518]
21. [21].Ko KP, Park SK, Park B, Yang JJ, Cho LY, Kang C, Kim CS, Gwack J, Shin A, Kim Y, Kim J, Yang HK, Kang D, Chang SH, Shin HR, Yoo KY. Isoflavones from phytoestrogens and gastric cancer risk: a nested case-control study within the Korean Multicenter Cancer Cohort. Cancer Epidemiol Biomarkers Prev 2010; 19: 1292-1300 [PMID: 20447921 DOI: 10.1158/1055-9965.EPI-09-1004]
22. [22].Rietjens IM, Sotoca AM, Vervoort J, Louisse J. Mechanisms underlying the dualistic mode of action of major soy iso- flavones in relation to cell proliferation and cancer risks. Mol Nutr Food Res 2013; 57: 100-113 [PMID: 23175102 DOI: 10.1002/mnfr.201200439]
23. [23].Hsieh CY, Santell RC, Haslam SZ, Helferich WG. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998; 58: 3833-3838 [PMID: 9731492]
24. [24]. van der Woude H, Gliszczynska-Swiglo A, Struijs K, Smeets A, Alink GM, Rietjens IM. Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans. Cancer Lett 2003; 200: 41-47 [PMID: 14550951 DOI: 10.1016/S0304-3835(03)00412-9]
25. [25]. Bulzomi P, Galluzzo P, Bolli A, Leone S, Acconcia F, Marino M. The pro-apoptotic effect of quercetin in cancer cell lines requires ERp-dependent signals. J Cell Physiol 2012; 227: 1891-1898 [PMID: 21732360 DOI: 10.1002/jcp.22917]
26. [26].van Erk MJ, Roepman P, van der Lende TR, Stierum RH, Aarts JM, van Bladeren PJ, van Ommen B. Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr 2005; 44: 143-156 [PMID: 15309432]
27. [27]. Alvarez M, Villanueva A, Acedo P, Canete M, Stockert JC. Cell death causes relocalization of photosensitizing fluorescent probes. Acta Histochem 2011; 113: 363-368 [PMID: 20138336 DOI: 10.1016/j.acthis.2010.01.008]
28. [28].Lovelace MD, Cahill DM. A rapid cell counting method utilising acridine orange as a novel discriminating marker for both cultured astrocytes and microglia. J Neurosci Methods 2007; 165: 223-229 [PMID: 17662460 DOI: 10.1016/ j.jneumeth.2007.06.009]
29. [29]. Moreno A, SantoDomingo J, Fonteriz RI, Lobaton CD, Mon- tero M, Alvarez J. A confocal study on the visualization of chromaffin cell secretory vesicles with fluorescent targeted probes and acidic dyes. J Struct Biol 2010; 172: 261-269 [PMID: 20600953 DOI: 10.1016/j.jsb.2010.06.015]
30. [30]. Tompkins WA, Watrach AM, Schmale JD, Schultz RM, Harris JA. Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum. J Natl Cancer Inst 1974; 52: 1101-1110 [PMID: 4826581]
31. [31].Picariello L, Fiorelli G, Benvenuti S, Brandi ML, Galli G, Malentacchi C, Montali E, Bigozzi U, Ficari F, Tonelli F. In vitro bioeffects of the antiestrogen LY117018 on desmoid tumors and colon cancer cells. Anticancer Res 1997; 17: 2099-2104
32. [32].Martineti V, Picariello L, Tognarini I, Carbonell Sala S, Gozzini A, Azzari C, Mavilia C, Tanini A, Falchetti A, Fio- relli G, Tonelli F, Brandi ML. ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocr Relat Cancer 2005; 12: 455-469 [PMID: 15947116]
33. [33].Cowley SM, Parker MG. A comparison of transcriptional activation by ER alpha and ER beta. J Steroid Biochem Mol Biol 1999; 69: 165-175 [PMID: 10418990]
34. [34].Hertog MGL, Hollman PCH, Katan MB. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 1992; 40: 2379-2383 [DOI: 10.1021/jf00024a011]
35. [35].Bartoll R, Fernandez-Banares F, Navarro E, Castella E, Mane J, Alvarez M, Pastor C, Cabre E, Gassull MA. Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis. Gut 2000; 46: 191-199 [PMID: 10644312]
36. [36].Hashim YZ, Eng M, Gill CI, McGlynn H, Rowland IR. Components of olive oil and chemoprevention of colorectal cancer. Nutr Rev 2005; 63: 374-386 [PMID: 16370222 DOI: 10.1111/j.1753-4887.2005.tb00374.x]
37. [37].Ross PD, Nominatori H, Davis JW and Yano K. A compari son of hip fracture incidence among native Japanese, Japanese Americans and American Caucasians. Am J Epidemiol 1991; 133: 801-809
38. [38]. Rosenberg Zand RS, Jenkins DJ, Diamandis EP. Flavonoids and steroid hormone-dependent cancers. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 777: 219-232 [PMID: 12270215]
39. [39].Hollman PC, de Vries JH, van Leeuwen SD, Mengelers MJ, Katan MB. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 1995; 62: 1276-1282 [PMID: 7491892]
40. [40].Dihal AA, Woutersen RA, van Ommen B, Rietjens IM, Stierum RH. Modulatory effects of quercetin on proliferation and differentiation of the human colorectal cell line Caco-2. Cancer Lett 2006; 238: 248-259 [PMID: 16129554 DOI: 10.1016/j.canlet.2005.07.007]
41. [41].Chen Z, Zheng W, Custer LJ, Dai Q, Shu XO, Jin F, Franke AA. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 1999; 33: 82-87 [PMID: 10227048 DOI: 10.1080/016355 89909514752]
42. [42]. Wakai K, Egami I, Kato K, Kawamura T, Tamakoshi A, Lin Y, Nakayama T, Wada M, Ohno Y. Dietary intake and sources of isoflavones among Japanese. Nutr Cancer 1999; 33: 139-145 [PMID: 10368808 DOI: 10.1207/S115327914NC330204]
43. [43].Arai Y, Uehara M, Sato Y, Kimira M, Eboshida A, Adler- creutz H, Watanabe S. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 2000; 10: 127-135 [PMID: 10778038 DOI: 10.2188/jea.10.127]
44. [44].van Erp-Baart MA, Brants HA, Kiely M, Mulligan A, Turrini A, Sermoneta C, Kilkkinen A, Valsta LM. Isoflavone intake in four different European countries: the VENUS approach. Br J Nutr 2003; 89 Suppl 1: S25-S30 [PMID: 12725653 DOI: 10.1079/BJN2002793]
45. [45].Bakker MI. RIVM rapport 320103002, Dietary intake of phytoestrogens. 2004. Available from: URL: http: / / www.rivm. nl/bibliotheek/rapporten/320103002.pdf
46. [46].Kuo SM. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett 1996; 110: 41-48 [PMID: 9018079 DOI: 10.1016/S0304-3835(96) 04458-8]
47. [47].Yu Z, Li W, Liu F. Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells. Cancer Lett 2004; 215: 159-166 [PMID: 15488634]
48. [48].Bandera EV, Williams MG, Sima C, Bayuga S, Pulick K, Wilcox H, Soslow R, Zauber AG, Olson SH. Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey. Cancer Causes Control 2009; 28..: 1117-1127 [PMID: 19353280 DOI: 10.1007/s10552-009-933 6-9]
49. [49].Kumar R, Verma V, Jain A, Jain RK, Maikhuri JP, Gupta G. Synergistic chemoprotective mechanisms of dietary phytoestrogens in a select combination against prostate cancer. J Nutr Biochem 2011; 22: 723-731 [PMID: 21062672 DOI: 10.1016/j.nutbio.2010.06.003]
50. [50].Sotoca AM, Ratman D, van der Saag P, Strom A, Gustafsson JA, Vervoort J, Rietjens IM, Murk AJ. Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio. J Steroid Biochem Mol Biol 2008; 112: 171-178 [PMID: 18955141 DOI: 10.1016/j.jsbmb.2008.10.002]
51. [51].Hsu HH, Cheng SF, Wu CC, Chu CH, Weng YJ, Lin CS, Lee SD, Wu HC, Huang CY, Kuo WW. Apoptotic effects of overexpressed estrogen receptor-beta on LoVo colon cancer cell is mediated by p53 signalings in a ligand-dependent manner. Chin J Physiol 2006; 49: 110-116 [PMID: 16830793]
52. [52].Arai N, Strom A, Rafter JJ, Gustafsson JA. Estrogen receptor beta mRNA in colon cancer cells: growth effects of estro gen and genistein. Biochem Biophys Res Commun 2000; 270: 425-431 [PMID: 10753641 DOI: 10.1006/bbrc.2000.2444]
53. [53]. Qiu Y, Waters CE, Lewis AE, Langman MJ, Eggo MC. Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor beta. J Endocrinol 2002; 174: 369-377 [PMID: 12208656 DOI: 10.1677/joe.0.1740369]
54. [54].Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA. Estrogen receptor beta inhibits 17beta-estra- diol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 2004; 101: 1566-1571 [PMID: 14745018]
55. [55].Schleipen B, Hertrampf T, Fritzemeier KH, Kluxen FM, Lorenz A, Molzberger A, Velders M, Diel P. ERp-specific agonists and genistein inhibit proliferation and induce apop- tosis in the large and small intestine. Carcinogenesis 2011; 32: 1675-1683 [PMID: 21856997 DOI: 10.1093/carcin/bgr188]
56. [56]. Kyle E, Neckers L, Takimoto C, Curt G, Bergan R. Genistein- induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol Pharmacol 1997; 51: 193-200 [PMID: 9203623]
57. [57]. So FV, Guthrie N, Chambers AF, Moussa M, Carroll KK. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer 1996; 26: 167-181 [PMID: 8875554]
58. [58].Hayashi SI, Eguchi H, Tanimoto K, Yoshida T, Omoto Y, Inoue A, Yoshida N, Yamaguchi Y. The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application. Endocr Relat Cancer 2003; 10: 193-202 [PMID: 12790782 DOI: 10.1677/erc.0.0100193]
59. [59].Brandenberger AW, Tee MK, Jaffe RB. Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues. J Clin Endocrinol Metab 1998; 83: 1025-1028 [PMID: 9506768 DOI: 10.1210/jc.83.3.1025]
60. [60]. Cheng J, Lee EJ, Madison LD, Lazennec G. Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett 2004; 566: 169-172 [PMID: 15147889 DOI: 10.1016/j.febs- let.2004.04.025]
61. [61].Rutherford T, Brown WD, Sapi E, Aschkenazi S, Munoz A, Mor G. Absence of estrogen receptor-beta expression in metastatic ovarian cancer. Obstet Gynecol 2000; 96: 417-421 [PMID: 10960636]